A novel monoclonal antibody to N-myristoyl glycine moiety found a new N-myristoylated HIV-1 p28(gag) protein in HIV-1-infected cells

被引:3
|
作者
Furuishi, K [1 ]
Misumi, S [1 ]
Shoji, S [1 ]
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM,KUMAMOTO 862,JAPAN
关键词
D O I
10.1006/bbrc.1996.0746
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel monoclonal antibody was raised against a synthetic N-myristoyl glycine that is characteristic of all N-myristoylated proteins. The immunoreaction suppressed in the presence of hemocyanin as well as albumin conjugated with N-myristoyl glycine and other N-myristoyl glycyl peptides, while underivatized and myristoyl amino acid proteins or various fatty acids other than myristic acid exerted no effect. The antibody specifically reacted with N-myristoylated pp60(c-src) in human colon adenocarcinoma cells, N-myristoylated pp60(v-src) in Rous sarcoma virus-infected cells, and N-myristoylated Gag precursor protein Pr55(gag) in HIV-1-producing cells. Furthermore, the antibody immunoreacted with a new N-myristoylated p28(gag) derived from HIV-1 gag protein. The antibody is shown to be a very useful tool for identification of N-myristoylated proteins. (C) 1996 Academic Press, Inc.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 10 条
  • [1] Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: Structural and mechanistic implications of p17 myristoylation
    Wu, ZB
    Alexandratos, J
    Ericksen, B
    Lubkowski, J
    Gallo, RC
    Lu, WY
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) : 11587 - 11592
  • [2] Enhanced production of p24 Gag protein in HIV-1-infected rat cells fused with uninfected human cells
    Chen, Jing
    Zhao, Xudong
    Lai, Yurong
    Suzuki, Akira
    Tomaru, Utano
    Ishizu, Akihiro
    Takada, Akio
    Ikeda, Hitoshi
    Kasahara, Masanori
    Yoshiki, Takashi
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 83 (01) : 125 - 130
  • [3] Novel strategy for anti-HIV-1 action:: selective cytotoxic effect of N-myristoyltransferase inhibitor on HIV-1-infected cells
    Takamune, N
    Hamada, H
    Misumi, S
    Shoji, S
    FEBS LETTERS, 2002, 527 (1-3) : 138 - 142
  • [4] Improved quantification of HIV-1-infected CD4+T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection
    Yang, Hongbing
    Yorke, Elisabeth
    Hancock, Gemma
    Clutton, Genevieve
    Sande, Nellia
    Angus, Brian
    Smyth, Redmond
    Mak, Johnson
    Dorrell, Lucy
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 391 (1-2) : 174 - 178
  • [5] The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE
    Schmalen, Adrian
    Karius-Fischer, Julia
    Rauch, Pia
    Setz, Christian
    Korn, Klaus
    Henklein, Petra
    Fossen, Torgils
    Schubert, Ulrich
    VIRUSES-BASEL, 2018, 10 (12):
  • [6] IDENTIFICATION OF PROTEIN INTERMEDIATES IN THE PROCESSING OF THE P55 HIV-1 GAG PRECURSOR IN CELLS INFECTED WITH RECOMBINANT VACCINIA VIRUS
    GOWDA, SD
    STEIN, BS
    ENGLEMAN, EG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (15) : 8459 - 8462
  • [7] Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O → N Acyloxy migration of P1 moiety
    Kazmierski, WM
    Bevans, P
    Furfine, E
    Spaltenstein, A
    Yang, HB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (15) : 2523 - 2526
  • [8] Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1(HIV-1) multiplication in infected MT-4 cells
    Ota, A
    Ueda, S
    HYBRIDOMA, 1999, 18 (03): : 235 - 241
  • [9] Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells
    Ota, A
    Bautista, AN
    Yadav, ML
    Ueda, S
    HYBRIDOMA, 1999, 18 (02): : 139 - 147
  • [10] TOOLS FOR THE PRODUCTION AND PURIFICATION OF FULL-LENGTH, N-TERMINAL OR C-TERMINAL P-32 LABELED PROTEIN, APPLIED TO HIV-1 GAG AND REV
    JENSEN, TH
    JENSEN, A
    KJEMS, J
    GENE, 1995, 162 (02) : 235 - 237